This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Royal College of Surgeons in Ireland. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Elaine Kay: Innovator in Colorectal Cancer Screening
Introduction
Elaine Kay is a notable inventor based in Dublin, Ireland. She has made significant contributions to the field of medical diagnostics, particularly in the assessment of colorectal cancer risk. Her innovative approach aims to improve early detection and patient outcomes.
Latest Patents
Elaine Kay holds a patent for a method of assessing colorectal cancer status in an individual. This invention relates to a method of screening patients to identify and quantify their risk of colorectal cancer. The method employs auto-antibodies that correlate with colorectal cancer risk and involves assaying a biological sample from the individual for a combination of biomarkers. The biomarkers are selected from SEQUENCE ID NO's: 1 to 12, ensuring that detection of all biomarkers indicates at least a 50% risk of the patient being positive for colorectal cancer. If all biomarkers are detected, it suggests that the patient should undergo a colonoscopy. Additionally, kits for performing this method are provided.
Career Highlights
Elaine has worked with prestigious institutions such as the Royal College of Surgeons in Ireland and Trinity College Dublin. Her work in these organizations has allowed her to contribute to significant advancements in medical research and diagnostics.
Collaborations
Elaine has collaborated with notable colleagues, including Gregor Kijanka and Dermot Kenny. Their combined expertise has furthered the development of innovative solutions in the medical field.
Conclusion
Elaine Kay's contributions to colorectal cancer screening exemplify the impact of innovation in healthcare. Her patented method represents a significant advancement in early detection, potentially saving lives through timely intervention.